A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases

Overview of attention for article published in mBio, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 42 news stories from 42 outlets.

MENLO PARK, Calif., Oct. 13, 2021. Aluda Pharmaceuticals announced the publication of "A Vimentin-targeting oral compound with…

- Novel antiviral actions: blocks viral entry and exit, plus facilitates viral clearance - Unique immune-balancing action: "Direc…

- Novel antiviral actions: blocks viral entry and exit, plus facilitates viral clearance - Unique immune-balancing action: "Direc…

- Novel antiviral actions: blocks viral entry and exit, plus facilitates viral clearance - Unique immune-balancing action: "Direc…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 38 additional news stories.